Skip to content
Clinical Trials – home
Research site

Gemeinschaftspraxis Dr. med. Josef und Dr. med. Wilma Großkopf

Germany Ahornstr. 2a, 94574 Wallerfing, Germany

  • 8 trials recruiting
  • Cardiac failure · Type 2 diabetes mellitus · Hypertriglyceridaemia
  • Adult patients

About Specializations

Gemeinschaftspraxis Dr. med. Josef und Dr. med. Wilma Großkopf in Wallerfing, Germany specialises in clinical trials of conditions such as Cardiac failure, Type 2 diabetes mellitus, Hypertriglyceridaemia, Dyslipidaemia, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Research

The site focuses on Cardiovascular Diseases, specifically investigating Atherosclerotic Cardiovascular Disease to test new treatments aimed at lowering the risk of major adverse cardiovascular events.

  • Evaluation of novel lipid‑lowering therapy
  • Prevention of myocardial infarction and stroke
  • Assessment of arterial revascularization outcomes

Gemeinschaftspraxis Dr. med. Josef und Dr. med. Wilma Großkopf contributes valuable data from its two investigators to advance heart health strategies.

Immune System Research

Studies at the practice target Immune System Diseases, with a key focus on Herpes Zoster and the evaluation of a vaccine designed to enhance immunity in older adults.

  • Long‑term immune response durability
  • Safety profile in elderly population
  • Impact on shingles incidence

The ongoing work supports the development of more effective preventive options for viral‑related immune challenges.

Viral Infection Studies

Within the realm of Virus Diseases, the practice examines Herpes Zoster to assess the performance of a preventive vaccine aimed at reducing disease burden.

  • Efficacy of recombinant subunit vaccine
  • Reduction of post‑herpetic neuralgia rates
  • Population‑level protection benefits

Located in Wallerfing, Germany, the site’s contributions help shape public‑health strategies against viral infections.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ahornstr. 2a94574 WallerfingGermany
Recruiting now
8 trials
Conditions studied
22

More sites in WallerfingGermany

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

19 clinical trials

Dyslipidaemia

Recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bempedoic Acid
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:ZILEBESIRAN
  • Sponsor:Alnylam Pharmaceuticals Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Sponsor:AstraZeneca AB

Cardiac failure

Recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim International GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim International GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Ivermectin
  • Sponsor:Dermapharm AG

Pharyngitis

Not yet recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:2,4 DICHLOROBENZYL ALCOHOL
  • Sponsor:MEDICE Arzneimittel Puetter GmbH & Co. KG

Hypertriglyceridaemia

Not recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
  • Sponsor:Arrowhead Pharmaceuticals Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Lavender Oil
  • Sponsor:Dr. Willmar Schwabe GmbH & Co. KG
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Respiratory Syncytial Virus, Glycoprotein F, Recombinant, Stabilised In The Pre-Fusion Conformation, Adjuvanted With As01E
  • Sponsor:GlaxoSmithKline Biologicals
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.